Abbott LaboratoriesABTNYSE
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank41
5Y CAGR-48.0%
Year-over-Year Change
Year-over-year revenue growth rate
5Y CAGR
-48.0%/yr
Long-term compound
Percentile
P41
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 0.79% |
| Q3 2025 | 2.04% |
| Q2 2025 | 7.57% |
| Q1 2025 | -5.61% |
| Q4 2024 | 3.19% |
| Q3 2024 | 2.49% |
| Q2 2024 | 4.14% |
| Q1 2024 | -2.70% |
| Q4 2023 | 0.97% |
| Q3 2023 | 1.65% |
| Q2 2023 | 2.37% |
| Q1 2023 | -3.41% |
| Q4 2022 | -3.06% |
| Q3 2022 | -7.52% |
| Q2 2022 | -5.36% |
| Q1 2022 | 3.72% |
| Q4 2021 | 4.94% |
| Q3 2021 | 6.90% |
| Q2 2021 | -2.23% |
| Q1 2021 | -2.29% |
| Q4 2020 | 20.87% |
| Q3 2020 | 20.81% |
| Q2 2020 | -5.15% |
| Q1 2020 | -7.07% |
| Q4 2019 | 2.95% |
| Q3 2019 | 1.22% |
| Q2 2019 | 5.89% |
| Q1 2019 | -2.96% |
| Q4 2018 | 1.42% |
| Q3 2018 | -1.43% |
| Q2 2018 | 5.10% |
| Q1 2018 | -2.62% |
| Q4 2017 | 11.13% |
| Q3 2017 | 2.89% |
| Q2 2017 | 4.77% |
| Q1 2017 | 18.79% |
| Q4 2016 | 0.58% |
| Q3 2016 | -0.58% |
| Q2 2016 | 9.17% |
| Q1 2016 | -5.84% |